Inhibition of Hepatitis C Virus Replication Induced by Chemotherapy: A Prospective Observational Study

被引：4
作者：
Hosry, Jeff [1 ]
Angelidakis, Georgios [1 ]
Kaseb, Ahmed [2 ]
Jiang, Ying [1 ]
Torres, Harrys A. [1 ,3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2018年 / 67卷 / 10期
基金：
美国国家卫生研究院;
关键词：
HEPATOCELLULAR-CARCINOMA; SORAFENIB;
D O I：
10.1093/cid/ciy387
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1635 / 1636
页数：2
相关论文
共 9 条
[1]   Sorafenib exposure decreases over time in patients with hepatocellular carcinoma [J].
Arrondeau, Jennifer ;
Mir, Olivier ;
Boudou-Rouquette, Pascaline ;
Coriat, Romain ;
Ropert, Stanislas ;
Dumas, Guillaume ;
Rodrigues, Manuel J. ;
Rousseau, Benoit ;
Blanchet, Benoit ;
Goldwasser, Francois .
INVESTIGATIONAL NEW DRUGS, 2012, 30 (05) :2046-2049
[2]   The anti-viral effect of sorafenib in hepatitis C-related hepatocellular carcinoma [J].
Cabrera, R. ;
Limaye, A. R. ;
Horne, P. ;
Mills, R. ;
Soldevila-Pico, C. ;
Clark, V. ;
Morelli, G. ;
Firpi, R. ;
Nelson, D. R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (01) :91-97
[3]   The kinase-inhibitor sorafenib inhibits multiple steps of the Hepatitis C Virus infectious cycle in vitro [J].
Descamps, Veronique ;
Helle, Francois ;
Louandre, Christophe ;
Martin, Elodie ;
Brochot, Etienne ;
Izquierdo, Laure ;
Fournier, Carole ;
Hoffmann, Thomas W. ;
Castelain, Sandrine ;
Duverlie, Gilles ;
Galmiche, Antoine ;
Francois, Catherine .
ANTIVIRAL RESEARCH, 2015, 118 :93-102
[4]   New mechanisms for old drugs: Insights into DNA-unrelated effects of platinum compounds and drug resistance determinants [J].
Gatti, Laura ;
Cassinelli, Giuliana ;
Zaffaroni, Nadia ;
Lanzi, Cinzia ;
Perego, Paola .
DRUG RESISTANCE UPDATES, 2015, 20 :1-11
[5]   Molecular Pathways: The Immunogenic Effects of Platinum-Based Chemotherapeutics [J].
Hato, Stanleyson V. ;
Andrea Khong ;
de Vries, I. Jolanda M. ;
Lesterhuis, W. Joost .
CLINICAL CANCER RESEARCH, 2014, 20 (11) :2831-2837
[6]   Management of Multiple Myeloma Complicated by Hepatitis C Virus Reactivation: The Role of New Antiviral Therapy [J].
Mahale, Parag ;
Thomas, Sheeba K. ;
Kyvernitakis, Andreas ;
Torres, Harrys A. .
OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (01)
[7]   Improving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load Criteria [J].
McGovern, Barbara H. ;
Birch, Christopher E. ;
Bowen, Melinda J. ;
Reyor, Laura L. ;
Nagami, Ellen H. ;
Chung, Raymond T. ;
Kim, Arthur Y. .
CLINICAL INFECTIOUS DISEASES, 2009, 49 (07) :1051-1060
[8]   Low Hepatitis C Viral Load Predicts Better Long-Term Outcomes in Patients Undergoing Resection of Hepatocellular Carcinoma Irrespective of Serologic Eradication of Hepatitis C Virus [J].
Shindoh, Junichi ;
Hasegawa, Kiyoshi ;
Matsuyama, Yutaka ;
Inoue, Yosuke ;
Ishizawa, Takeaki ;
Aoki, Taku ;
Sakamoto, Yoshihiro ;
Sugawara, Yasuhiko ;
Makuuchi, Masatoshi ;
Kokudo, Norihiro .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06) :766-773
[9]   Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study [J].
Torres, Harrys A. ;
Hosry, Jeff ;
Mahale, Parag ;
Economides, Minas P. ;
Jiang, Ying ;
Lok, Anna S. .
HEPATOLOGY, 2018, 67 (01) :36-47
1